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1. Introduction 
The presence of cystathionine synthase (L-serine 
hydro-lyase (adding homocysteine), EC 4.2.1.21 [see 
11) in the brain tissue was first shown by Hope [2] , 
who presented the direct evidence by isolating 
cystathionine after incubating DL-homocysteine and 
L-serine in-the rat brain homogenate. Despite extensive 
study on the relationship between cystathionine or 
cystathionine synthase and brain function [3-51, 
little has been attempted as to biochemical character- 
ization of brain cystathionine synthase, unlike the 
liver enzyme [6-91. The report from this laboratory 
[lo] showed that in the rat brain the developmental 
pattern of cystathionine synthase activity was con- 
siderably different from that in the liver, and also 
suggested a possible attachment of approximately 
half the enzyme activity to the subcellular particles in 
the brain tissue. The present communication reports 
on the localization of cystathionine synthase activity 
of rat brain, both in the mitochondrial and the soluble 
fractions, and also on the attempts to solubilize the 
mitochondrial enzyme. 
2. Materials and methods 
The brain tissue rostral to the inferior colliculi was 
used throughout the experiments. Subcellular fractions 
were prepared at O-4” from the brain homogenate of 
rats (2.50-350 g in body weight) as described by 
Eichberg et al. [ 111. The identity of the fractions was 
confirmed by electron-microscopic examination carried 
out by Dr. J. Asai. 
Cystathionine synthase activity was assayed as 
described previdusly [6, lo] with 60 min incubation 
North-Holland Publishing Company - Amsterdam 
as a routine. Cupric sulfate was introduced into the 
incubation mixtures, as was the case also in crude 
liver preparations [ 121. Succinate dehydrogenase was 
used as a mitochondrial marker [ 131 and was assayed 
as succinate-tetrazolium reductase [ 141 . A unit was 
defined as the amount that yielded one pmole of 
cystathionine or formazan per min. Protein was deter- 
mined by a biuret method [15, 161 with bovine serum 
albumin as a standard. 
3. Results and discussion 
Volpe et al. [4] , on the basis of the studies on the 
regional distribution of cystathionine and cystathionine 
synthase in monkey brain, suggested that cystathionine 
might be synthesized in the perikaryon of neurons 
and then migrate along the axons to accumulate in 
areas of white matter. In this laboratory it was found 
that in rat brain tissue approximately half the enzymic 
activity of cystathionine synthase was associated with 
particulate fraction [lo] . Table 1 confirms this ob- 
servation. When the brain homogenate was fraction- 
ated into four fractions, i.e., nuclear (p,),mitochondrial 
(PZ), microsomal (Ps) and soluble (S) fractions, the 
activity of cystathionine synthase was distributed 
mainly in two fractions. One was P, fraction (37%) 
and the other S fraction (43%). The activity of suc- 
cinate dehydrogenase, a mitochondrial marker, was 
exclusively found in P, fraction (92%). When the crude 
mitochondrial fraction (PZ) was then subfractionated 
into myelin @‘,A), synaptosomal (PP,B) and mitochon- 
drial (P,C) fractions in a discontinuous sucrose density 
gradient, more than 80% of the activity of cystathion- 
ine synthase was detected in the P,C fraction (table 2). 
The pattern of the distribution was nearly similar to 
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Table 1 
November 1971 
Subcellular localization of cystathionine synthase and succinate dehydrogenase in rat brain I. Fractionation of homogenate. 
Fraction Pl p2 p3 S 
Conditions 
Precipitate 
at 1lOOg 
10 min 
--~ 
(%) (RSA) 
Precipitate 
at 17,500 g 
60 min 
~- 
(%) (RSA) 
Preciplatte 
at 105,000 g 
60 min 
(%) (RSA) 
Supernatant 
at 105,000 g 
60min 
(%) WA 
Protein 11 64 4 21 
CTS 17 1.5 37 0.6 3 0.8 43 2.0 
SDH 7 0.6 92 1.4 1 0.3 0 0.0 
Recoveries for the fractions from homogenate were 91% for protein, 111% for cystathionine synthase (CTS) and 86% for succinate 
dehydrogenase (SDH). The results were means of four separate xperiments and expressed as percentages of the sum of the frac- 
tions. RSA (relative specific activity) was a ratio of (% of recovered activity)/(% of recovered protein). 
that of succinate dehydrogenase activity, approxim- 
ately 75% of which was found in P,C fraction. Mito- 
chondria thus separated came from nerve endings, 
neuronal perikarya and glia cells. The present findings 
can not show in which mitochondria the activity of 
cystathionine synthase mainly localizes. However, 
this enzyme is reported more abundant in grey matter 
than in white matter in primate brain [4]. It is, there- 
fore, possible to consider that the high concentration 
of the enzyme in the P,C fraction might be contributed 
by neuronal perikarya and/or synaptic endings, not by 
glia cells. 
Table 2 
Subcellular localization of cystathionine synthase and succin- 
ate dehydrogenase in rat brain II. Fractionation of crude mito- 
chondrial fraction (Pa). 
Fraction P2A P2B p2c 
Conditions 
Subfractions of Pa in a gradient 
53,000 g, 2 hr 
---- 
(%) (RSA) (%) (RSA) (5) (RSA) 
Protein 21 45 34 
Cl8 9 0.4 8 0.2 83 2.4 
SDH 3 0.1 22 0.5 75 2.2 
________~ 
Recoveries for the fractions from crude mitochondrial fraction 
were 71% for protein, 74% for cystathionine synthase (CTS) 
and 57% for succinate dehydrogenase (SDH). The results were 
means of four separate xperiments and expressed in the same 
manner as in table 1. 
Table 3 shows the effects of various treatments on 
release of cystathionine synthase in a crude mitochon- 
drial fraction (P2). A freshly prepared P,-free super- 
natant was divided equally into 5 portions and centri- 
fuged at 17,500 g for 60 min. The P, thus obtained 
was treated as shown in the table. The percent distri- 
bution of the enzymic activity was approximately 80 
and 20 in 105,000 g supernatant and precipitate, 
respectively, with treatments of Triton X-100 and 
sonic oscillation. Interestingly the activities in the 
supernatants increased approximately twofold, as 
compared with non-treated P, . High specific activities 
of the enzyme were also obtained in the supernatants 
(7.1 X 10e3 for Triton X-100 and 10.3 X 10e3 for 
sonic oscillation). Since both Triton X-100 and sonic 
oscillation treatments disrupt mitochondrial mem- 
branes, it is possible to assume that the enzyme local- 
izes in the mitochondrial matrix in a loosely bound 
form. This assumption may be supported by the 
finding that the osmotic shock at a final sucrose con- 
centration of 0.064 M, which was reported to reduce 
the solubility of the enzyme contained in the matrix 
of mitochondria [ 171 and to rupture the synaptic 
endings without irreversible damage of mitochondria 
[ 181 , resulted in some release of cystathionine syn- 
thase with relatively high specific activity (4.4 X 10e3 ). 
This may be due to mechanical disruption of mito- 
chondria during homogenization. The osmotic shock 
at a sucrose concentration of 0.032 M caused more 
release of the enzyme from mitochondria than that at 
0.064 M, and gave a higher specific activity (8.5 X 
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Table 3 
Effects of various treatments on cystathionine synthase activity of crude mitochondrial fraction. 
105,000 g supematant 105,000 g precipitate 
Specific Activity Specific Activity 
Treatment activity activity Sum of Recovery 
(units/mg (units/mg activity of 
protein (units protein (units (units activity 
x 1000) x 1000) x 1000) x 1000) x 1000) (%J 
-- -- 
None _ _ 2.1 132 132 100 
% Distribution 100 
Triton X- 100 7.1 253 2.3 63 316 239 
% Distribution 80.1 19.9 
Sonic oscillation 10.3 305 2.6 87 392 297 
% Distribution 77.9 22.1 
0.064 M sucrose 4.4 48 2.5 131 179 136 
% Distribution 26.6 73.4 
0.032 M sucrose 8.5 101 1.6 82 183 139 
% Distribution 55.4 44.6 
- - 
Crude mitochondrial fractions were treated at a protein concentration of 13 mg per ml by 0.2% Triton X-100 in 0.32 M sucrose, 
sonic oscillation (20 Kc for 7 min in 0.32 M sucrose), 0.064 M sucrose and 0.032 M sucrose, and centrifuged at 105,000 g for 60 
min. Each precipitate was resuspended in 0.32 M sucrose with brief homogenization. 
10d3) in the same degree as Triton X-100 and sonic 
oscillation treatments. As was the case of aspartate 
aminotransferase in rat brain [ 181, the observation 
that the recoveries of cystathionine synthase after 
various treatments were always in excess of 100% 
(table 3) may show the possibility that the enzyme in 
the mitochondrial fraction is an “occluded” or “latent” 
enzyme and protected from the access of the exogen- 
ous substrates, homocysteine and/or serine. At the 
present stage it is not clear whether the mitochondrial 
and the soluble enzyme are the same, or are isozymes. 
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